Anthem (ANTM) and Its Peers Head to Head Comparison

Anthem (NYSE: ANTM) is one of 14 public companies in the “Managed Health Care” industry, but how does it contrast to its rivals? We will compare Anthem to similar companies based on the strength of its profitability, dividends, valuation, analyst recommendations, institutional ownership, earnings and risk.

Profitability

This table compares Anthem and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Anthem 3.35% 12.97% 4.97%
Anthem Competitors 1.70% 10.28% 3.36%

Valuation and Earnings

This table compares Anthem and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Anthem $88.03 billion $5.75 billion 19.11
Anthem Competitors $52.70 billion $3.80 billion 18.36

Anthem has higher revenue and earnings than its rivals. Anthem is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Dividends

Anthem pays an annual dividend of $2.80 per share and has a dividend yield of 1.3%. Anthem pays out 25.3% of its earnings in the form of a dividend. As a group, “Managed Health Care” companies pay a dividend yield of 0.9% and pay out 20.7% of their earnings in the form of a dividend. Anthem has raised its dividend for 2 consecutive years.

Volatility & Risk

Anthem has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Anthem’s rivals have a beta of 0.76, suggesting that their average stock price is 24% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Anthem and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anthem 0 8 9 0 2.53
Anthem Competitors 79 880 1442 23 2.58

Anthem presently has a consensus price target of $192.53, indicating a potential downside of 8.90%. As a group, “Managed Health Care” companies have a potential downside of 2.67%. Given Anthem’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Anthem has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

88.1% of Anthem shares are held by institutional investors. Comparatively, 90.3% of shares of all “Managed Health Care” companies are held by institutional investors. 0.4% of Anthem shares are held by company insiders. Comparatively, 2.5% of shares of all “Managed Health Care” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Anthem rivals beat Anthem on 9 of the 15 factors compared.

About Anthem

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.

What are top analysts saying about Anthem Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Anthem Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit